Medscape July 29, 2024
The European Centre for Disease Prevention and Control estimates that about 5.4 million people in the European Union and European Economic Area (EU/EAA) live with chronic hepatitis B or C infection.
Many of these people are undiagnosed.
Still many others who do get diagnosed do so at advanced stages when severe health issues have developed. Chronic hepatitis resulting from B or C virus infection is one of the main risk factors for primary liver cancer — the sixth leading cause of cancer-related deaths in Europe, with 55,000 deaths in 2022 alone.
“Primary care practitioners have a critical role in supporting the achievement of elimination of hepatitis,” said Erika Duffell, MB, ChB, principal expert in hepatitis at the European Centre for...